LUCHINI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 11.750
EU - Europa 11.270
AS - Asia 9.339
SA - Sud America 1.699
AF - Africa 386
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 10
Totale 34.480
Nazione #
US - Stati Uniti d'America 11.425
RU - Federazione Russa 4.720
SG - Singapore 3.718
CN - Cina 2.403
GB - Regno Unito 1.713
IT - Italia 1.694
BR - Brasile 1.339
HK - Hong Kong 978
VN - Vietnam 870
DE - Germania 613
IE - Irlanda 571
FR - Francia 537
SE - Svezia 471
BD - Bangladesh 331
FI - Finlandia 294
KR - Corea 293
CA - Canada 163
IN - India 150
NL - Olanda 142
AR - Argentina 133
JP - Giappone 119
UA - Ucraina 97
MX - Messico 95
TR - Turchia 77
NG - Nigeria 73
AT - Austria 70
ID - Indonesia 66
ES - Italia 65
ZA - Sudafrica 64
EC - Ecuador 62
BJ - Benin 60
PL - Polonia 58
TG - Togo 54
IQ - Iraq 53
BE - Belgio 39
VE - Venezuela 37
MA - Marocco 34
PK - Pakistan 32
CO - Colombia 31
PY - Paraguay 28
UZ - Uzbekistan 28
CL - Cile 26
PH - Filippine 26
CZ - Repubblica Ceca 22
CH - Svizzera 21
KE - Kenya 21
AU - Australia 20
SA - Arabia Saudita 20
MY - Malesia 19
PE - Perù 19
TN - Tunisia 19
HR - Croazia 16
AE - Emirati Arabi Uniti 14
JO - Giordania 14
AL - Albania 12
AZ - Azerbaigian 12
EG - Egitto 12
IR - Iran 12
LT - Lituania 12
LV - Lettonia 12
NP - Nepal 12
BO - Bolivia 11
JM - Giamaica 11
KZ - Kazakistan 11
OM - Oman 11
DZ - Algeria 10
PT - Portogallo 10
RO - Romania 10
SK - Slovacchia (Repubblica Slovacca) 10
UY - Uruguay 10
CR - Costa Rica 9
KG - Kirghizistan 9
RS - Serbia 9
IL - Israele 8
NI - Nicaragua 8
BY - Bielorussia 7
LB - Libano 7
NO - Norvegia 7
PS - Palestinian Territory 7
SN - Senegal 7
CY - Cipro 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
SI - Slovenia 6
SV - El Salvador 6
HU - Ungheria 5
TH - Thailandia 5
AM - Armenia 4
AO - Angola 4
DK - Danimarca 4
EE - Estonia 4
GA - Gabon 4
HN - Honduras 4
MK - Macedonia 4
PA - Panama 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BB - Barbados 3
Totale 34.403
Città #
Singapore 1.841
Moscow 1.583
Ashburn 1.549
Dallas 1.401
Southend 1.351
San Jose 1.344
Chandler 1.045
Hong Kong 931
Verona 758
Dublin 543
Beijing 483
The Dalles 481
New York 372
Council Bluffs 317
Jacksonville 291
Ho Chi Minh City 285
Woodbridge 266
Los Angeles 233
Ann Arbor 203
Houston 189
Lawrence 181
Princeton 181
Munich 178
Hanoi 175
Wilmington 148
São Paulo 141
Buffalo 131
Helsinki 124
Redondo Beach 123
Jinan 118
Nanjing 112
Santa Clara 111
London 104
Milan 101
Tokyo 100
Columbus 99
Shenyang 91
Redmond 86
Sindelfingen 82
Abuja 71
Seattle 67
Montreal 65
Orem 65
Hebei 61
Cotonou 60
Tianjin 58
Turku 58
Guangzhou 55
Rome 55
Zhengzhou 55
Lomé 54
Amsterdam 51
Rio de Janeiro 51
Warsaw 50
Ningbo 49
Changsha 48
Da Nang 48
Redwood City 47
Hangzhou 46
Nuremberg 46
Seoul 44
Frankfurt am Main 43
Johannesburg 43
Bologna 42
Stockholm 42
Taizhou 42
Toronto 41
Shanghai 40
Vienna 40
Brussels 39
Haikou 39
Taiyuan 38
Chennai 37
Haiphong 36
Phoenix 36
San Francisco 36
Chicago 35
Lancaster 35
Nanchang 35
Atlanta 33
Brooklyn 33
Lappeenranta 33
Poplar 33
Denver 31
Paris 31
Belo Horizonte 30
Falkenstein 29
Jakarta 29
Jiaxing 28
Mexico City 28
Washington 28
Brasília 27
Madrid 24
Boston 23
Naples 23
Boardman 22
Dong Ket 22
Hải Dương 21
Mumbai 21
Tashkent 21
Totale 20.325
Nome #
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 297
Genomic characterization of hepatoid tumors: context matters 261
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 259
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 248
Tumor-like lesionsof the pancreas. 242
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 239
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 226
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 217
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 216
Adherence to the Mediterranean diet is associated with better quality of life: data from the Osteoarthritis Initiative 214
Adenocarcinoma of the paraurethral glands: a case report 213
CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications 202
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 201
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 201
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment 200
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 199
Different Prognostic Roles Of Tumor Suppressor Gene BAP1 In Cancer: A Systematic Review With Meta-Analysis 199
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 199
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis 198
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 198
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 196
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 195
Sex differences in oncogenic mutational processes 195
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 195
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 194
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 194
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 188
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 188
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 188
Epstein-Barr Virus-associated gastric cancer: a histopathologic study with comprehensive molecular profiling 187
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 185
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 185
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 185
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
CD13 is a useful tool in the differential diagnosis of meningiomas with potential biological and prognostic implications 181
Fhit down-regulation is an early event in pancreatic carcinogenesis 177
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 177
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 176
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 175
Tracheobronchopathia Osteochondroplastica: A Case Report Illustrating the Importance of Multilevel Workup Clinical, Endoscopic and Histological Assessment in Diagnosis of an Uncommon Disease 175
Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease 174
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 172
Pathological complete response in a patient affected by multiple synchronous, breast and lung primary malignancies: a case report and review of the literature 169
Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative 169
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 169
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases 169
Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance 167
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 167
Loss of FGFR4 promotes the malignant phenotype of PDAC 166
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 163
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 162
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 161
Exosomal miRNA signatures of pancreatic lesions 161
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 161
Extranodal extension is an important prognostic parameter for both colonic and rectal cancer 160
High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis 160
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 160
Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles 159
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 159
Serous Neoplasms 158
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 158
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 157
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma 156
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 156
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 156
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 155
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer 155
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 154
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 154
Either High or low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum Of Pancreas-specific Complications After Pancreatoduodenectomy 153
Metastatic malignant melanoma to the gallbladder. Case report and review of the literature 153
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 153
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 153
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 151
CARATTERISTICHE CLINICO-PATOLOGICHE, PROFILO MOLECOLARE E BERSAGLI PER L’IMMUNOTERAPIA NEI CARCINOMI INDIFFERENZIATI DEL PANCREAS CON CELLULE GIGANTI SIMIL-OSTEOCLASTICHE 151
Inflammatory and tumor-like lesions of the pancreas 151
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 151
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy 150
Malignant epithelial/exocrine tumors of the pancreas 150
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 149
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 149
Circulating tumour DNA: a challenging innovation to develop "precision onco-surgery" in pancreatic adenocarcinoma 149
Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions 148
Long-term organoid culture of a small intestinal neuroendocrine tumor 147
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach 147
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 147
Mucinous Neoplasms 146
Artificial intelligence in oncology: current applications and future perspectives 146
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 146
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 145
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 144
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 144
Artificial Intelligence for Predicting Microsatellite Instability Based on Tumor Histomorphology: A Systematic Review 144
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary 142
Endoscopic ultrasound guided fine needle biopsy samples to drive personalized medicine: A proof of concept study 140
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 139
Evaluating Mismatch Repair Deficiency for Solid Tumor Immunotherapy Eligibility: Immunohistochemistry versus Microsatellite Molecular Testing 139
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 138
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 137
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 137
Totale 17.374
Categoria #
all - tutte 126.289
article - articoli 121.730
book - libri 0
conference - conferenze 642
curatela - curatele 0
other - altro 420
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.497
Totale 252.578


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 0 66
2021/20221.468 108 378 66 123 35 36 43 129 68 39 95 348
2022/20233.134 206 333 284 520 250 777 51 205 352 40 74 42
2023/20242.166 92 166 161 222 233 318 198 152 40 96 369 119
2024/20256.034 324 282 259 912 301 211 377 317 867 466 564 1.154
2025/202618.290 1.234 997 1.634 2.785 4.249 1.043 1.509 1.110 1.560 1.039 484 646
Totale 35.229